(Q41515366)

2 October 2017

1 reference

title

Role of Bcr-Abl kinase in resistance to apoptosis (English)

1 reference

2 October 2017

Role of Bcr-Abl Kinase in Resistance to Apoptosis (English)

0 references

Afshin Samali

1

0 references

author name string

Samali A

1

1 reference

2 October 2017

Gorman AM

2

1 reference

2 October 2017

Cotter TG

3

1 reference

2 October 2017

Adrienne M. Gorman

2

0 references

Thomas G. Cotter

3

0 references

publication date

1 January 1997

1 reference

2 October 2017

1997

0 references

number of pages

20

1 reference

inferred from page(s)

published in

Advances in Pharmacology

1 reference

2 October 2017

41

1 reference

2 October 2017

533-552

1 reference

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Chronic myelogenous leukemia--new concepts (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Protein or RNA synthesis inhibition induces apoptosis of mature human CD4+ T cell blasts

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Induction of apoptosis in fibroblasts by c-myc protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Apoptotic cell death induced by c-myc is inhibited by bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Bcl-2 and the regulation of programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Mutant H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The mouse c-abl locus: molecular cloning and characterization.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Isolation and characterization of Caenorhabditis elegans DNA sequences homologous to the v-abl oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The Drosophila Abelson proto-oncogene homolog: identification of mutant alleles that have pleiotropic effects late in development.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Alternative 5' exons in c-abl mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Protein modules and signalling networks

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Abelson virus-induced lymphomagenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Bcr encodes a GTPase-activating protein for p21rac

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Clonal Origin of Chronic Myelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Regulation of the Fas apoptotic cell death pathway by Abl.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Identification of the potential active site of the signal peptidase SipS of Bacillus subtilis. Structural and functional similarities with LexA-like proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Regulators and Effectors of ras Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Differential complementation of Bcr-Abl point mutants with c-Myc

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Retroviral mediated gene transfer in chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2961071-6

7 January 2021

10.1016/S1054-3589(08)61071-6

Identifiers

DOI

0 references

1 reference